New Ag Products

ZuraLac™ is specifically formulated to sanitize and protect teats from mastitis causing organisms, and protect teat skin tissue from harsh environmental conditions.

Learn More

Funding Boost

Updated 5/22/2012

MIDDLETON, Wis., – Zurex Pharma, Inc. (Zurex), a life sciences company with a novel antimicrobial technology platform, announced today it has raised $6.2 million in Series A financing, led by Baird Venture Partners and the State of Wisconsin Investment Board ...

Read Full Article

ZuraPrep™

Presurgical skin preparation for the prevention of surgical site infections.

ZurAsept™

Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

ZuraGard™

Prevention of extra-luminal or “exit site” wound catheter-related bloodstream infections.

Publications

Read more about the Zurex product lines from other publications and scientific journals.

Visit Publications Page

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with healthcare acquired infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).